HOME >> BIOLOGY >> NEWS
If airbags work well, then Mars landing sites can be chosen more boldly, says UB geologist

BUFFALO, N.Y. -- The anticipated Mars landing on Jan. 24 of the Opportunity rover will be a bit more challenging than the Spirit's bounce onto the red planet earlier this month, according to a University at Buffalo geologist, but if it's successful, then scientists will be able to be much bolder about selecting future Mars landing sites.

"If both of these landers survive with airbag technology, then it blows the doors wide open for future Mars landing sites with far more interesting terrain," said Tracy Gregg, Ph.D., University at Buffalo assistant professor of geology in the UB College of Arts and Sciences and a planetary volcanologist.

Gregg, who headed a national conference at UB in 1999 regarding the selection of future Mars landing sites, is chair of the geologic mapping standards committee of the NASA Planetary Cartography Working Group. "With the success of Spirit, I feel so much more confident about future Mars landers," said Gregg. "The airbags seem to be able to withstand quite a bit of trauma."

Gregg remembers attending a conference presentation a few years ago by Matt P. Golombek, Ph.D., planetary geologist at the Jet Propulsion Laboratory and, at the time, the principal investigator on the Mars Pathfinder mission, in which he proposed the airbag landing technology.

"He listed the 15 steps that had to happen at exactly the right time and in exactly the right way in order for this technology to work. The general mood in the lecture hall was, 'Yeah, right, good luck,'" Gregg remembered. "Well, the next year, he got up to a standing-room-only crowd at a meeting of the same organization and he described all of the same steps that the Pathfinder had successfully completed on Mars. He got a standing ovation."

The selection of Mars landing sites is a complex balancing act, Gregg says, where the potential for important scientific discoveries has to be balanced against the requirement that sites be absolutely safe so that the rove
'"/>

Contact: Ellen Goldbaum
goldbaum@buffalo.edu
716-645-5000 x1415
University at Buffalo
15-Jan-2004


Page: 1 2

Related biology news :

1. In Laos, a rare deer is discovered alive and well, despite war and over-hunting
2. Beagle 2 team still hopes to repeat Mars landing success
3. Cervantes mission concludes with Soyuz TMA-2 landing
4. 9/11 search-and-rescue dogs exhibit few effects from exposure to disaster sites
5. NSF awards $10 million in grants to ocean sites for long-term ecological research
6. Yale researchers discover new potential asthma therapeutic targets related to parasites and insects
7. Nutrients cause increase in parasites and frog deformities
8. Scientists call for less destructive remediation at DOE sites
9. Researchers probe how microbes speed up acid production at mining sites
10. Parasites mediate plant invasions
11. Parasites prevent ants from protecting coffee plants

Post Your Comments:
(Date:12/10/2014)... WINSTON-SALEM, N.C. , Dec. 9, 2014  Wake Forest ... medical education building for its School of Medicine. Funding ... a larger capital campaign that will be publicly launched ... will be located in the former 60 series R.J. ... Forest Innovation Quarter. Construction will begin immediately with plans ...
(Date:12/5/2014)... VIEW, Calif. , Dec. 4, 2014 /PRNewswire/ ... safety has boosted investments in new testing and ... has also given rise to a range of ... by the requirements of Generation Y, which is ... technologies. As a result, product development strategies of ...
(Date:12/3/2014)... , Dec. 2, 2014 As part ... readers, Inception Technologies is pleased to announce the release ... for customers to collect the workforce data that they ... that have been left by existing readers. Many such ... interface, connectivity and modern technology. Older models force users ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2
(Date:12/17/2014)... Xeno Diagnostics has again received ... recent COLA inspection. Xeno has met all criteria ... accreditation organization. Accreditation is earned only by laboratories ... operations, demonstrate continued accuracy in the performance of ... survey. , While the Laboratory Excellence ...
(Date:12/17/2014)... , Dec. 17, 2014 CASI Pharmaceuticals, ... dedicated to the acquisition, development and commercialization of innovative ... the global market with a primary commercial focus on ... has been granted a Type C meeting with the ... meeting will be held in February 2015.  During this ...
(Date:12/15/2014)... DIEGO , Dec. 15, 2014 ... three-dimensional biology company focused on delivering breakthrough 3D ... the industry and collaborators of its exVive3D TM ... made widely available in full commercial release on ... the field, resulting in several awards for innovation. ...
(Date:12/13/2014)... and Virgin Unite Canada, the non-profit foundation of the Virgin ... Canadian entrepreneurs tackling social and environmental challenges. Today, Sir ... Centre to announce the new partnership, which includes the development ... $1 million in seed capital provided by Virgin Unite Canada ... Foundation, founded by Alison Lawton . ...
Breaking Biology Technology:Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3MaRS and Virgin Unite partner to invest in business as a force for good 2MaRS and Virgin Unite partner to invest in business as a force for good 3
Cached News: